Navigation Links
New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy

Rochester, NY (PRWEB) April 30, 2013

Tremor, visual and auditory hallucinations, confusion and coma are neuropsychiatric side effects, and all have been associated with the use of Valacyclovir (Valtrex). (2)

“Valacyclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection.” (3) It is also the most popular drug prescribed against Genital Herpes infection due to its “ease of administration….” (1)

However, problems with brain function are just the tip of the iceberg. reports a laundry list of Valtrex side effects, including “Gastrointestinal side effects (that) have included nausea (up to 15% of users), abdominal pain (up to 11% of users), and vomiting (up to 6% of users). (4)

“I’ve never been able to understand why someone would take a drug to get rid of an annoying symptom, and in return get a potentially life-threatening symptom.” – Mike Davis, polyDNA

In light of the many potential side effects associated with Valtrex, polyDNA recommends Gene-Eden-VIR against the latent herpes virus. Valtrex is a chemical drug, in contrast, Gene-Eden-VIR is a natural herpes remedy that has no reported side effects.

In a post marketing clinical study, Gene-Eden-VIR was shown to be safe and highly effective against the latent herpes viruses. Over 70% of Gene-Eden-VIR users reported a reduction in herpes symptoms. (5)

Gene-Eden-VIR is highly effective against the latent herpes viruses, each ingredient was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of HSV. (6)

Finally, according to, the cost of a month’s supply of Valtrex (90 pills), one of the most common anti-herpes medications, is $1275 for the brand name at the CVS Pharmacy. (7) The cost of the generic brand is only slightly less. In contrast, a month’s supply of Gene-Eden-VIR is $37.99. That’s over a thousand dollars less than the cost of Valtrex.

To learn more about Gene-Eden-VIR, visit




polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
2. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
3. Nature Materials study: Boosting heat transfer with nanoglue
4. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
5. Nature Materials study: Graphene invisible to water
6. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
7. Drink to Your (Oral) Health: Atlanta Dentist Looks at Two Recent Studies Exploring Green Tea’s Effects on Oral Health
8. Probiotic Action Explains New Research that Probiotics Help Reduce Stress Side Effects
9. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
10. ?The Employment Report for January, 2013: Wrapping Up the Year in Employment Statistics: Recovery Efforts and the Coming Effects
11. University of Miami study finds RBAC to possess promising immunomodulating effects with respect to natural killer cell and cytokine activity
Post Your Comments:
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
(Date:11/24/2015)... SHPG ) announced today that Jeff ... 27 th Annual Healthcare Conference in New York ... a.m. EST (1:30 p.m. GMT). --> SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
(Date:11/24/2015)... ... 2015 , ... In harsh industrial processes, the safety of ... can represent a weak spot where leaking process media is a possible hazard. ... , which are designed to tolerate extreme process conditions. They combine rugged design ...
(Date:11/24/2015)... Nov. 24, 2015 HemoShear Therapeutics, LLC, ... drugs for metabolic disorders, announced today the appointment ... Board of Directors (BOD). Mr. Watkins is the ... Genome Sciences (HGS), and also served as the ... Jim Powers , Chairman and CEO of HemoShear ...
Breaking Biology Technology:
(Date:11/18/2015)...  As new scientific discoveries deepen our understanding of ... providers face challenges in better using that knowledge to ... as more children continue to survive pediatric cancer, that ... age. John M. Maris, M.D ., a ... (CHOP) . --> John M. Maris, ...
(Date:11/17/2015)... , November 17, 2015 Paris ... 2015.   --> Paris from 17 ... DERMALOG, the biometrics innovation leader, has invented the first ... fingerprints on the same scanning surface. Until now two different ... Now one scanner can capture both on the same ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
Breaking Biology News(10 mins):